EO-4426

N/A

Report date: 2026/03/10 20:00:16

Base Information

Drug NameEO-4426
Drug Alias NameTezacitabine替扎他滨TezacitabinumTezacitabinaEO-4426 +[6] 
ClassificationSmall molecules
Mechanisms of ActionDNA polymerase alpha subunit inhibitorsRibonucleotide reductase inhibitors
TargetsDNA polymerase alpha subunitRibonucleotide reductase
Therapy Area/IndicationsSolid tumoursHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEdison Oncology Holding Corp
China Registration ClassN/A

Develop Information

Active CompaniesValent Technologies LlcEdison Oncology Holding Corp
Inactive CompaniesN/A
Active IndicationsSolid tumoursHematologic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A